Proventil-hfa Patent Expiration

Proventil-hfa is a drug owned by Kindeva Drug Delivery Lp. It is protected by 3 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Dec 28, 2016. Details of Proventil-hfa's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6006745 Device for delivering an aerosol
Dec, 2016

(7 years ago)

Expired
US5775321 Seal configuration for aerosol canister
Jul, 2015

(9 years ago)

Expired
US5605674 Medicinal aerosol formulations
Feb, 2014

(10 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Proventil-hfa is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Proventil-hfa's family patents as well as insights into ongoing legal events on those patents.

Proventil-hfa's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Proventil-hfa's generic launch date based on the expiry of its last outstanding patent is estimated to be Dec 28, 2016 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Proventil-hfa Generic API suppliers:

Albuterol Sulfate is the generic name for the brand Proventil-hfa. 46 different companies have already filed for the generic of Proventil-hfa, with Teva having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Proventil-hfa's generic

How can I launch a generic of Proventil-hfa before its drug patent expiration? :

You can seek FDA approval to launch a generic drug before the expiration of Proventil-hfa's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Proventil-hfa's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Given below are the details of the already filed Para IV certificates on Proventil-hfa -

Strength Submission Date ANDA(s) Filed First applicant approval Last patent expiry 180 day status
0.09 mg base per actuation 20 May, 2015 1 28 Dec, 2016 Extinguished

Alternative Brands for Proventil-hfa

There are several other brand drugs using the same active ingredient (Albuterol Sulfate) as Proventil-hfa. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name
Astrazeneca
Airsupra
Boehringer Ingelheim
Combivent
Combivent Respimat
Glaxosmithkline
Ventolin Hfa
Norvium Bioscience
Accuneb
Duoneb
Teva Branded Pharm
Proair Digihaler
Proair Hfa
Proair Respiclick


Apart from brand drugs containing the same ingredient, some generics have also been filed for Albuterol Sulfate, Proventil-hfa's active ingredient. Check the complete list of approved generic manufacturers for Proventil-hfa





About Proventil-hfa

Proventil-Hfa is a drug owned by Kindeva Drug Delivery Lp. Proventil-Hfa uses Albuterol Sulfate as an active ingredient. Proventil-Hfa was launched by Kindeva in 1996.

Approval Date:

Proventil-hfa was approved by FDA for market use on 15 August, 1996.

Active Ingredient:

Proventil-hfa uses Albuterol Sulfate as the active ingredient. Check out other Drugs and Companies using Albuterol Sulfate ingredient

Dosage:

Proventil-hfa is available in aerosol, metered form for inhalation use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
EQ 0.09MG BASE/INH AEROSOL, METERED Prescription INHALATION